COVID-19 Accentuated the Demand for AI in Precision Medicine Market due to Rising Number of Patient

DELTA, British Columbia - Aug. 26, 2020 - PRLog -- The higher adoption of AI in precision medicine can be witnessed by the healthcare professional to improve accuracy and prediction of the patient due to advances in genetic disease, autoimmune diseases, and precision oncology.The AI in precision medicine is growing at an astonishing rate owing to the factors such as introduction of precision medicine for the various chronic diseases such as cancer and cardiovascular disease, intensification in government spending by launching research centre and various merger and acquisition by the companies. For instance, The Icahn School of Medicine at Mount Sinai plans to open worth USD100 million research centres focused on artificial intelligence (AI) and precision medicine in Manhattan in late 2021.

Moreover, the COVID-19 pandemic accelerated the demand for AI in precision medicine due to the use of precision medicine to increase the survival rate of patient suffering from COVID-19. For instance, Precision Life data scientis tused an AI enabled precision medicine platform to identify high risk genes for COVID-19 in 2020. The aim of the company is to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19,

According to MarkNtel Advisors' research report "Global AI in Precision Medicine Market Analysis, 2020", the market size of AI in Precision Medicines in Global is anticipated to grow at a CAGR of around 50% during 2020-25. Based on End-User, Oncology is gaining momentum in the Global AI in precision medicine market on account of snowballing rate of cancer patient in the coming years and introduction of various artificial intelligence technology in the cancer treatment. Hence, it is anticipated to bolster the demand for AI in precision medicine in the forecasted period.

2019 and developed artificial intelligence technology for cancer treatment, accelerating precision medicine and improving patient care.

View Report:
https://www.marknteladvisors.com/query/request-sample/global-artificial-intelligence-in-precision-medicine-market.html

North America Exhibited the highest share in the AI in Precision Medicine market

North America attained the largest market in the AI in Precision Medicine market in 2019 on account of the proliferating adoption of AI technology, escalating government spending in R&D of AI and precision medicine and launch of precision medicine strategy for various diseases. Thus, it is strongly accelerating the demand for AI in precision medicine in the forecasted period.